ClinicalTrials.gg
CompletedNCT03467009iPACTUpdated Nov 26, 2019

Bullying Prevention Intervention for Adolescent Primary Care Patients

An interventional study of iPACT Intervention and Control: Enhanced Usual Care (EUC) in Cyberbullying, sponsored by Rhode Island Hospital. Completed at 1 site in United States. Open to participants aged 13 Years to 17 Years. Per ClinicalTrials.gov, last updated 2019-11-26.

Sponsored by Rhode Island Hospital · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
77
Allocation
Randomized
Ages
13 Years to 17 Years
Sex
All
01

Study summary

The purpose of this randomized controlled study is to evaluate acceptability and feasibility, and to gather preliminary data about efficacy, of "iPACT" (intervention to Prevent Adolescent Cyber-victimization with Text messages), a brief in-clinic introductory session + longitudinal automated text-message-based secondary prevention program for adolescents with a history of past-year cyber-victimization presenting to a pediatric clinic for well-child visits.

Read the detailed description

Cyber-victimization predicts depressive symptoms and suicidality; it correlates with PTSD symptoms, alcohol and other drug use, physical peer violence, and dating violence.

Almost 80% of adolescents have a well-child visit with their pediatrician each year. Pediatricians recognize this visit as an important opportunity for behavioral screening, interventions, and referrals, but they currently lack cyber-victimization interventions that are feasible and effective in the clinical setting. Personalized text-message interventions are accessible, feasible, and may be effective with these adolescents.

The purpose of this study is to test the feasibility and acceptability of a novel text-message-augmented secondary prevention intervention, "iPACT." Drawing on effective cognitive behavioral therapy (CBT) and motivational interviewing (MI) depression and violence prevention interventions, a brief in-clinic session will introduce basic cognitive and behavioral strategies. Following their clinic visit, eight weeks of tailored CBT-informed daily text messages will be sent, to enhance skills and remind participants of self-determined goals.

Participants will be identified in the course of usual clinical care. If eligible, parents will be consented and participants assented. Participants will complete a baseline assessment and will be randomized to experimental (iPACT, n=25) or enhanced usual care (EUC, n=25) care, using stratified block randomization.

iPACT group participants will participate in a brief, structured in-clinic introduction on CBT and the iPACT program, followed by 8 weeks of tailored, two-way, CBT-and MI-informed automated text messages (short message service, SMS). EUC group participants will receive standardized information on cyberbullying. The current standard of care for these patients is no care: no cyber-victimization screening assessment protocols are currently used in our clinic. Both iPACT and EUC conditions therefore exceed current levels of care.

At baseline, 8 week follow-up, and 16 week follow-up, participants will complete assessments on cyberbullying, peer violence, and cognitive/behavioral skill-sets. At the 8-week follow-up, standardized qualitative and quantitative process measures will be administered to assess efficacy, acceptability, usability, and feasibility.

02

Conditions studied

  • Cyberbullying

Browse trials for

Keywords

  • cyber-victimization
  • text message
  • mhealth
03

In context

Cyberbullying

25 studies on the registry are indexed under Cyberbullying; 8 are open to participants now.

This study's enrollment of 77 is below the median of 150 across 21 interventional studies indexed under Cyberbullying.

Browse Cyberbullying studies →

Lead sponsor

Rhode Island Hospital is the lead sponsor of 192 studies on the registry; 37 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • presenting to Hasbro Children's pediatric clinic
  • being mentally and physically able to assent
  • being English-speaking
  • having a consentable parent present
  • self-reporting cyber-victimization (defined as endorsing >1 past-year episode of technology-mediated victimization)

Exclusion criteria

Exclusion Criteria:

  • being cognitively or emotionally unable to take part in the intervention as determined by the pediatric attending clinician
  • suspected by clinical staff of being a victim of child abuse
  • currently incarcerated or under police custody
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
77 participants (actual)

Study arms

  • Experimental
    iPACT Intervention

    1. In-clinic brief session, introducing basic principles of cognitive behavioral theory and the structure of the text-message portion of the intervention. 2. Eight-week longitudinal tailored CBT-based text-message program.

    Behavioral: iPACT Intervention

  • Active comparator
    Control: Enhanced Usual Care (EUC)

    The investigators will provide participants with a standard resource sheet with information on bullying and mental health resources.

    Other: Control: Enhanced Usual Care (EUC)

  • Experimental
    iPACT Intervention- App

    1. In-clinic brief session, introducing basic principles of cognitive behavioral theory and the structure of the message portion of the intervention delivered via app. 2. Eight-week longitudinal tailored CBT-based message program delivered via app.

    Behavioral: iPACT Intervention- app

Interventions

  • BehavioraliPACT Intervention

    Brief in-person + tailored, daily 8-week text-message secondary prevention intervention.

  • OtherControl: Enhanced Usual Care (EUC)

    EUC group participants will receive standardized information on cyberbullying.

  • BehavioraliPACT Intervention- app

    Brief in-person + tailored, daily 8-week message secondary prevention intervention delivered via app.

06

What researchers measure

Primary outcomes

  1. Intervention Acceptability: Enrollment Rate

    Enrollment Rate: % of eligible participants who consented and completed enrollment

    Time frame: Enrollment

  2. Intervention Acceptability: Change in Follow Up Rate from 8 weeks post-enrollment to 16 weeks post-enrollment

    Retention Rate: % of consented participants who completed follow up

    Time frame: 8 weeks post-enrollment (close of intervention), 16 weeks post-enrollment (8 wks after close of intervention)

  3. Intervention Acceptability: Participant Satisfaction

    Text Customer Satisfaction Questions

    Time frame: 8 weeks post-enrollment (close of intervention)

  4. Intervention Feasibility: Participant Engagement

    Among the intervention group, how many participants responded to at least one of the daily text message queries, and how many requested on-demand support text-messages.

    Time frame: Enrollment to 8 weeks post-enrollment (close of intervention)

Secondary outcomes

  1. Change in cyber-victimization between enrollment, 8 weeks post-enrollment, and 16 weeks post-enrollment

    Modified version of the University of New Hampshire Internet Safety Education Survey (Jones et al. 2012); investigators selected 5 items from the survey to measure. Items are scored by participants' self-report of online harassment experiences ranging from 0 ("Never") to 4 ("7 or more times"). Possible score range of 0-20, with higher scores indicating greater number of online harassment experiences.

    Time frame: Enrollment, 8 weeks post-enrollment (close of intervention), 16 weeks post-enrollment

  2. Change in cyber-victimization emotional impact between enrollment, 8 weeks post-enrollment, and 16 weeks post-enrollment

    Modified version of the Cyber-Victimization Emotional Impact Scale (Elipe et al. 2015); investigators selected 7 of the 18 items to measure. Items are scored by participants' self-report of feelings ranging from 0 ("Not at all") to 4 ("Extremely"). Possible score range of 0-28, with higher scores indicating greater degree of emotional impact.

    Time frame: Enrollment, 8 weeks post-enrollment (close of intervention), 16 weeks post-enrollment

  3. Change in cyber-victimization related behaviors between enrollment, 8 weeks post-enrollment, and 16 weeks post-enrollment

    Comprised of 5 items from the Bystander Intervention in Bullying Measures (Nickerson et al. 2014) and 8 items from the University of New Hampshire Internet Safety Education Survey (Jones et al. 2012). Items are scored by participants' self-report of online bystander behavior ranging from 1 ("Strongly disagree") to 5 ("Strongly agree"). Possible score range of 13-65, with higher scores indicating greater personal responsibility/self-efficacy to intervene when witnessing online harassment experiences.

    Time frame: Enrollment, 8 weeks post-enrollment (close of intervention), 16 weeks post-enrollment

07

Study locations

1 site
  • Rhode Island Hospital
    Providence, Rhode Island 02903, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2018 to primary completion in Jun 2019, 15 months.

Of 19 interventional studies with no phase under Cyberbullying, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 14. This study's 15 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 27, 2018
First posted
Mar 15, 2018
StartActual
Mar 6, 2018
Primary completionActual
Jun 12, 2019
CompletionActual
Jul 31, 2019
Last update
Nov 26, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 26, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03467009
Responsible party
Sponsor
First posted
Mar 15, 2018
Start date
Mar 6, 2018
Primary completion
Jun 12, 2019
Completion
Jul 31, 2019
Last update
Nov 26, 2019

Study contacts

Megan L Ranney, MD MPH
principal investigator · Rhode Island Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion